Abstract
Two classes of fused nitrogen heterocycles were designed as CK2 inhibitor candidates on the basis of previous structure-activity relationship (SAR) studies. Various dipyrrolo[3,2-b:2',3'-e]pyridine and benzo[g]indazole derivatives were prepared using transition-metal-catalysed cascade and/or multicomponent reactions. Biological evaluation of these candidates revealed that benzo[g]indazole is a promising scaffold for potent CK2 inhibitors. The inhibitory activities on cell proliferation of these potent CK2 inhibitors are also presented.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Casein Kinase II / antagonists & inhibitors*
-
Catalysis
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Copper / chemistry*
-
Gold / chemistry*
-
Heterocyclic Compounds / chemistry*
-
Heterocyclic Compounds / pharmacology
-
Humans
-
Models, Molecular
-
Molecular Structure
-
Nitrogen Compounds / chemistry*
-
Nitrogen Compounds / pharmacology
-
Protein Kinase Inhibitors / chemical synthesis*
-
Protein Kinase Inhibitors / pharmacology
-
Structure-Activity Relationship
Substances
-
Heterocyclic Compounds
-
Nitrogen Compounds
-
Protein Kinase Inhibitors
-
Gold
-
Copper
-
Casein Kinase II